Loxasperse® contains Xylitol NF, Poloxamer 407 USP, and Poloxamer 188 USP. The Xylitol component, in general terms, is the reason that advertising for chewing gums containing Xylitol say chewing the gum helps to kill gingivitis (bacteria). Poloxamers reduce particle size and increase the solubility and dispersibility of accompanying drugs.
As a stand-alone excipient powder within a compounded capsule
As a stand-alone excipient powder, such as a 30gram container, that could be used topically to an external area
In a compounded capsule with active pharmaceutical ingredients (drugs)
Improving Drug Delivery
Poloxamers in LX reduce particle size and increase the solubility and dispersibility of accompanying drugs
More Convenient and Simplified Process
LX, in dry-powder capsules, are more convenient and portable than liquid solutions.
It’s ideal for multi-drug therapy because it’s dispensed as a powder, which reduces the risk of drug compatibility and storage/stability concerns that come with water-containing compounded medications.
The powder/capsule preparation provides a longer beyond-use date than compounded medications using a water-containing base and requires neither refrigeration nor preservatives.
Additional Benefits
May have synergistic activity with common antimicrobial agents